Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

NCT03945318 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: BION-1301 Single Dose
DRUG: Placebo Single Dose
DRUG: BION-1301 Multiple Doses
DRUG: Placebo Multiple Doses
DRUG: BION-1301 Single Dose

Sponsor

Novartis Pharmaceuticals